PLX

PROTALIX BIOTHERAPEUTICS INC

PLX·74365A309·US·Common Stock·Healthcare - Biotechnology-13D/G

PLX (PROTALIX BIOTHERAPEUTICS INC) is held by 64 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($7.8M), RENAISSANCE TECHNOLOGIES LLC ($2.7M), STATE STREET CORP ($2.1M). Net institutional sentiment: Mixed.

64
Holders
Avg rating(15 Elite)
$23.6M
Total Value
67% (68)
Fund Consensus
38 buying - 19 selling
PLXSmart Money Verdict
View all
Held by 64 funds
15 elite
Who's Trading
ActivistMAMAK Capital Fund LP4.5%Mar 30, 2026
InsiderBDBashan DrorBuy $101KDec 19, 2025
InsiderBABar-Shalev AmosSell $314.16Nov 18, 2025
InsiderSASchwartz AharonBuy $206KJun 10, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
3.6M(-0.8%)$7.8M0.0%+51.91%
0
Decreased
1.2M(-3.0%)$2.7M0.0%+45.36%
0
Increased
972,815(+66.2%)$2.1M0.0%+15.84%
38
Increased
885,448(+2.3%)$1.9M0.0%+36.08%
26
Increased
865,298(+4.3%)$1.9M0.0%+52.99%
27
New
432,485$938,4920.0%-13.78%
38
Increased
301,793(+128.7%)$654,8900.0%+5.47%
27
Increased
296,843(+932.7%)$643,7890.0%-10.06%
39
Increased
265,535(+1.1%)$576,2110.0%+29.75%
25
Decreased
251,345(-4.4%)$545,4180.0%+16.28%
0
Increased
219,307(+4.0%)$475,8960.0%+46.32%
25
Decreased
207,275(-10.7%)$449,7870.0%-4.39%
0
Decreased
159,311(-9.0%)$345,7050.0%+58.44%
0
Unchanged
90,188$195,7080.0%+58.44%
0
Increased
86,617(+21.3%)$187,9590.0%+26.32%
27
Increased
79,079(+70.6%)$171,6010.0%+14.01%
23
Increased
74,985(+8763.5%)$162,7170.0%-13.55%
36
New
63,351$137,4720.0%-13.78%
34
Increased
53,478(+51.6%)$117,0000.0%+23.29%
21
Increased
49,085(+27.4%)$106,5140.0%-7.36%
18

Showing 1-20 of 68

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used